What is more, although near univocally described as an oncogene and driver of transformation, in gastric and non-small lung cell carcinoma SOX2 expression was in fact reported as a favorable molecular prognostic factor [55–59]. The gene discussed is SOX2; the disease is non-small cell lung carcinoma.